Will post-transplantation cell therapies for pediatric patients become standard of care?

Authors

Arjan C Lankester
Franco Locatelli
Peter Bader
Eva Rettinger
Maarten Egeler
Satyendra Katewa
Catherine M. Bollard, George Washington UniversityFollow
+ 6 more

Document Type

Journal Article

Publication Date

3-1-2015

Journal

Biology of blood and marrow transplantation

Volume

21

Issue

3

Inclusive Pages

402-11

DOI

10.1016/j.bbmt.2014.07.018

Keywords

Cell- and Tissue-Based Therapy--methods; Graft Rejection--prevention & control; Graft vs Host Disease--therapy; Graft vs Tumor Effect; Hematologic Neoplasms--therapy; Hematopoietic Stem Cell Transplantation.

APA Citation

Lankester AC, Locatelli F, Bader P, Rettinger E, Egeler M, Katewa S, et als. (2015) Will post-transplantation cell therapies for pediatric patients become standard of care? Biology of blood and marrow transplantation; 21(3):402-11. doi: 10.1016/j.bbmt.2014.07.018.

Peer Reviewed

1